| Group A | Group B | Group C | Test value | P value | Sig. | Post hoc analysis | |||
---|---|---|---|---|---|---|---|---|---|---|
No. = 228 | No. = 177 | No. = 326 | P1 | P2 | P3 | |||||
Procedure | CA | 99 (43.4%) | 66 (37.3%) | 116 (35.6%) | 14.507* | 0.024 | S | 0.215 | 0.009 | 0.662 |
CA + PCI | 69 (30.3%) | 57 (32.2%) | 93 (28.5%) | |||||||
CA + PTCA | 3 (1.3%) | 0 (0.0%) | 0 (0.0%) | |||||||
PCI | 57 (25.0%) | 54 (30.5%) | 117 (35.9%) | |||||||
No. of vessels | 0 | 42 (18.4%) | 18 (10.2%) | 38 (11.7%) | 41.574* | 0.000 | S | 0.000 | 0.000 | 0.435 |
1 | 102 (44.7%) | 54 (30.5%) | 87 (26.7%) | |||||||
2 | 48 (21.1%) | 66 (37.3%) | 111 (34.0%) | |||||||
3 | 36 (15.8%) | 39 (22.0%) | 87 (26.7%) | |||||||
4 | 0 (0.0%) | 0 (0.0%) | 3 (0.9%) | |||||||
LM disease | 11(4.8%) | 21(11.8)% | 34(10.4%)) | 7.418 | 0.0245 | S | 0.009 | 0.01 | 0.6 | |
Gensini score | Median (IQR) | 35.75 (24–64.5) | 66 (49–94) | 65 (36–96) | 72.404≠| 0.000 | S | 0.000 | 0.000 | 0.967 |
Range | 0–152 | 0–135 | 0–156 | |||||||
Type of stent | No | 0 (0.0%) | 3 (2.7%) | 3 (1.4%) | 6.393* | 0.172 | NS | – | – | – |
BMS | 0 (0.0%) | 3 (2.7%) | 3 (1.4%) | |||||||
DES | 120 (100.0%) | 105 (94.6%) | 204 (97.1%) | |||||||
No. of stents | 0 | 3 (2.4%) | 3 (2.7%) | 3 (1.4%) | 22.963* | 0.003 | S | 0.103 | 0.000 | 0.331 |
1 | 78 (63.4%) | 54 (48.6%) | 90 (42.9%) | |||||||
2 | 39 (31.7%) | 48 (43.2%) | 99 (47.1%) | |||||||
3 | 0 (0.0%) | 3 (2.7%) | 15 (7.1%) | |||||||
4 | 3 (2.4%) | 3 (2.7%) | 3 (1.4%) | |||||||
Length | Median (IQR) | 33 (21.5–50) | 42 (32.5–59) | 48 (28–66) | 16.055≠| 0.000 | S | 0.004 | 0.000 | 0.500 |
Range | 12–110 | 12–96 | 10–147 |